Published in Biochemistry on October 31, 1995
Delineation of prognostic biomarkers in prostate cancer. Nature (2001) 12.25
Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry (1985) 11.80
Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell (1999) 6.90
Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev (1995) 4.22
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12
Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI. Proc Natl Acad Sci U S A (1987) 4.03
Laboratory investigations of resistance to warfarin of Rattus norvegicus Berk. In Montgome norvegicus Berk. in Montgomeryshire and Shropshire. Ann Appl Biol (1968) 3.82
Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry (1984) 3.75
Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science (1988) 3.40
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37
The Drosophila zeste gene and transvection. Trends Genet (1989) 3.15
Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci U S A (1982) 3.14
Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem (1991) 2.79
Interactions of zeste mutations with loci exhibiting transvection effects in Drosophila melanogaster. Genetics (1982) 2.78
Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother (1986) 2.74
The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol (1988) 2.36
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A (1989) 2.28
Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25
The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol (1979) 2.21
Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. Eur J Biochem (1989) 2.12
Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry (1985) 1.94
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res (1998) 1.92
Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A (1981) 1.91
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90
Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci U S A (1986) 1.89
A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry (1988) 1.89
Reversible immunocontraception in male monkeys immunized with eppin. Science (2004) 1.84
Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol (1995) 1.83
Activation of human factor IX (Christmas factor). J Clin Invest (1978) 1.82
Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci U S A (1988) 1.76
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A (1998) 1.75
Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci U S A (1985) 1.75
Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg (2001) 1.74
Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet (1989) 1.74
Molecular cloning of a full-length cDNA for human alcohol dehydrogenase. Proc Natl Acad Sci U S A (1985) 1.74
Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer (2001) 1.73
Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes. Nature (1982) 1.70
Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. J Biol Chem (1977) 1.68
Lipocalins: unity in diversity. Biochim Biophys Acta (2000) 1.64
Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res (1994) 1.63
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.63
Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol (2001) 1.63
Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry (1986) 1.62
Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry (1984) 1.62
Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (1995) 1.57
Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res (2000) 1.54
Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet (1995) 1.52
Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis (1988) 1.52
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene (2001) 1.48
Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health (2009) 1.48
Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab (1982) 1.47
The molecular defects of alpha-thalassemia in the Filipino. Hemoglobin (1977) 1.47
Sst I RFLP in the human inter-alpha-trypsin inhibitor heavy chain gene ITIH1. Nucleic Acids Res (1988) 1.44
Has the incidence of radiation-induced bowel damage following treatment of uterine carcinoma changed in the last 20 years? J R Soc Med (1986) 1.42
Early seizures after severe closed head injury. Can J Neurol Sci (1997) 1.41
Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol (1990) 1.40
Pigmented neurofibrosarcoma mimicking a large haemangioma. Clin Exp Dermatol (1990) 1.39
A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol (1991) 1.39
A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem (1990) 1.37
Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci U S A (1984) 1.36
Rat two-generation reproductive toxicity study of bisphenol A. Reprod Toxicol (2002) 1.34
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol (1999) 1.33
Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol Endocrinol (2000) 1.32
An intragenic deletion of the factor IX gene in a family with hemophilia B. J Clin Invest (1985) 1.32
Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth (2006) 1.31
Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci U S A (1992) 1.30
Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry (1986) 1.29
MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings. AJNR Am J Neuroradiol (2001) 1.28
Characterization of human, bovine, and horse antithrombin III. Biochemistry (1976) 1.28
Regional localization of the human factor IX gene by molecular hybridization. Hum Genet (1983) 1.28
Two modes of transvection: enhancer action in trans and bypass of a chromatin insulator in cis. Proc Natl Acad Sci U S A (1998) 1.27
Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol (1994) 1.27
A web-based pedometer programme in women with a recent history of gestational diabetes. Diabet Med (2012) 1.25
Core promoter elements can regulate transcription on a separate chromosome in trans. Genes Dev (1999) 1.25
Malignant tumors in choledochal cysts. Ann Surg (1977) 1.24
A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res (1996) 1.23
Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology (1990) 1.23
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J (1981) 1.23
Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer (2011) 1.22
Long-term results of hepaticojejunostomy for hepatolithiasis. Am Surg (2001) 1.22
Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). Biochemistry (1977) 1.21
Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer (2000) 1.20
Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem (1976) 1.20
Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. J Virol (1991) 1.20
Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol (1992) 1.20
Antitumor beta glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull (2001) 1.20
Erythroid progenitors circulating in the blood of adult individuals produce fetal hemoglobin in culture. Science (1978) 1.19
Microvascular angiogenesis and apoptosis in the survival of free fat grafts. Laryngoscope (2000) 1.19
Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene (2000) 1.18
The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest (2000) 1.17
Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry (1986) 1.16
Inhibition of bovine factor IXa and factor Xabeta by antithrombin III. Biochemistry (1976) 1.16
Cloning and sequencing of human Eppin: a novel family of protease inhibitors expressed in the epididymis and testis. Gene (2001) 1.16
Bilateral pulmonary edema after endoscopic sympathectomy in a patient with glucose-6-phosphate dehydrogenase deficiency. Acta Anaesthesiol Scand (2001) 1.15
Role of intron I in expression of the human factor IX gene. J Biol Chem (1995) 1.15
Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol (2001) 1.15
Structures of triclinic mono- and di-N-acetylglucosamine: lysozyme complexes--a crystallographic study. J Mol Biol (1976) 1.15
Further evidence of a target organ defect in the syndrome of testicular feminization. J Clin Endocrinol Metab (1966) 1.14